Loading insider details...
Latest Form 4 (Nov 3, 2026): Tax Withholding of 9,540 PCRX shares, $347.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Pacira BioSciences, Inc. (PCRX) | Tax Withholding | 9,540 | $347.2K |
| Apr 25, 2026 | Pacira BioSciences, Inc. (PCRX) | Exercise/Conversion | 12,941 | $212.9K |
| Apr 23, 2026 | Pacira BioSciences, Inc. (PCRX) | Exercise/Conversion | 7,714 | $126.9K |
| Feb 13, 2026 | Pacira BioSciences, Inc. (PCRX) | Grant/Award | 49,091 | n/a |
| Dec 11, 2025 | Pacira BioSciences, Inc. (PCRX) | Exercise/Conversion | 15,896 | $261.5K |
| Nov 13, 2025 | Pacira BioSciences, Inc. (PCRX) | Sale | 12,060 | $266.4K |
| Nov 3, 2025 | Pacira BioSciences, Inc. (PCRX) | Tax Withholding | 6,690 | $143.0K |
| Nov 5, 2024 | Pacira BioSciences, Inc. (PCRX) | Grant/Award | 75,000 | n/a |
| Aug 20, 2024 | Cyclo Therapeutics, Inc. (CYTH) | Grant/Award | 9,028 | n/a |
| Jun 5, 2024 | Cyclo Therapeutics, Inc. (CYTH) | Grant/Award | 8,887 | n/a |